Fibrous dysplasia of the bone. Contribution of Nuclear Medicine in the Diagnosis of Suspicion of Sarcomatous Degeneration

Chinchilla, A. Santiago; Font, C. Ramos; Moreno, M. Tello; Aguirre, A.C. Rebollo; Laínez, Martínez; Peinado, M. Gallego; Elvira, J.M. Llamas

doi:10.1016/s1578-200x(10)70049-8

Cited by 5 publications

(3 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 36 The images are obtained at 3 time points: at the time of injection, after a few minutes, and finally, after 3 to 5 hours, pinpointing uptake of the radiotracer within the lesion and indicating possible extension in the earliest stages of the disease. 37 …”

Section: Methodsmentioning

confidence: 99%

New technologies in oral radiology as a diagnostic aid for monostotic fibrous dysplasia: a review

Acha

Llaguno-Rubio

2022

Rev Cient Odontol (Lima)

View full text Add to dashboard Cite

Monostotic fibrous dysplasia is a benign asymptomatic lesion that affects only one bone, which is replaced by amorphous connective tissue. Clinically there is an increase in the volume of the affected area, which is observed by imaging as a radiopaque area with diffuse non-corticalized limits capable of expanding to neighboring structures, and it is histologically evidenced as “resembling Chinese characters”. The lesion is seen as a radiopaque image with diffuse borders in conventional or digital radiography, while cone beam computed tomography identifies the exact location and extension of an isodense, mixed or hyperdense image of non-corticalized edges. Magnetic resonance imaging is also used when the lesion involves soft tissues or nerves, and bone scintigraphy is performed in order to systemically observe bone quality. The objective of this article was to describe the new technologies in oral radiology for the diagnosis of monostotic fibrous dysplasia and the importance of the current imaging methods in achieving an adequate diagnosis. These techniques range from conventional radiography to bone scans, which provide images of higher quality, clarity and better precision with less invasive techniques to the patient. This review of the literature helps to expand the knowledge of dental professionals in relation to the clinical and imaging characteristics of monostotic fibrous dysplasia.

show abstract

Section: Methodsmentioning

confidence: 99%

New technologies in oral radiology as a diagnostic aid for monostotic fibrous dysplasia: a review

Acha

Llaguno-Rubio

2022

Rev Cient Odontol (Lima)

View full text Add to dashboard Cite

show abstract

“…Fibrous dysplasia can have variable FDG uptake, and in some cases intense FDG activity. In such situations, it is important to differentiate benign tumors from any possibility of a sarcomatous changes [39]. Hemangiomas can also be a site of intense FDG activity which can sometimes mimic metastasis.…”

Section: Benign Tumorsmentioning

confidence: 99%

Current role of FDG-PET in Bone and Soft tissue tumors

Ansari¹,

Munker²,

Takalkar³

2015

Journal of Bone and Soft Tissue Tumors

View full text Add to dashboard Cite

FDG-PET/CT imaging is an established modality for the workup of several malignancies; it is now considered standard for the initial as well as a subsequent treatment strategy in the management of most malignancies. The focus of this article is to discuss the role of FDG-PET/CT imaging in the workup and management of malignant bone and soft tissue tumors in conjunction with standard imaging techniques like MRI and CT scanning. The article also briefly touches upon the potential role of emerging PET-MRI modality.

show abstract

“…But it should be kept in mind that increased FDG uptake may suggest the possibility of sarcomatous change. 45…”

Section: Fibrous Dysplasiamentioning

confidence: 99%

PET/CT in Benign and Malignant Musculoskeletal Tumors and Tumor-Like Conditions

Choi

Kim

Yang

2014

Semin Musculoskelet Radiol

View full text Add to dashboard Cite

This article briefly reviews malignant bone tumors, diffuse marrow infiltrating diseases, and other benign bone diseases with fluorodeoxyglucose (FDG) uptake on positron emission tomography/computed tomography (PET/CT) that should be differentiated from malignant tumors. Clinical use of FDG PET/CT in (1) primary malignant bone tumors including osteosarcoma, malignant fibrous histiocytoma, and primary bone lymphoma, (2) hematopoietic tumors with bone marrow involvement, such as plasmacytoma, multiple myeloma, lymphoma and leukemia, and (3) benign tumors and tumor-like lesions including hemangioma, neurogenic tumor, fibrous dysplasia, and nodular fasciitis are presented, with an emphasis on various imaging findings on FDG PET/CT. Benign tumors and tumor-like conditions are often incidentally detected on FDG PET/CT in serial follow-up studies of cancer patients and should be differentiated from metastasis.

show abstract

Fibrous dysplasia of the bone. Contribution of Nuclear Medicine in the Diagnosis of Suspicion of Sarcomatous Degeneration

Cited by 5 publications

References 14 publications

New technologies in oral radiology as a diagnostic aid for monostotic fibrous dysplasia: a review

New technologies in oral radiology as a diagnostic aid for monostotic fibrous dysplasia: a review

Current role of FDG-PET in Bone and Soft tissue tumors

PET/CT in Benign and Malignant Musculoskeletal Tumors and Tumor-Like Conditions

Contact Info

Product

Resources

About